首页> 外文会议>Annual Meeting of the American Association of Swine Veterinarians >Evaluation of a one-dose Mycophtsma hyopneumoniae bacterin and a one-dose Erysipelas rhusiopathie bacterin
【24h】

Evaluation of a one-dose Mycophtsma hyopneumoniae bacterin and a one-dose Erysipelas rhusiopathie bacterin

机译:评价一剂霉菌疫苗菌药和一剂红霉菌细菌菌药

获取原文

摘要

Novartis Animal Vaccines Inc. is introducing a new line of one-dose vaccines. This line will include both bacterins and viral vaccines, all of which will provide protection in a single 1 ml dose. These products contain a unique adjuvant composed of water in oil in water (ImmunStar~(TM)). The objective of this study was to determine if the bacterins PneumoSTAR~(TM) Myco and PanSTAR~(TM) Ery containing this novel adjuvant would protect swine against experimental challenge with My-coplasma hyopneumoniae and Erysipelas rhusiopathie, respectively.
机译:Novartis Animal Vaccines Inc.正在引入一系列一剂疫苗。该系列将包括菌药和病毒疫苗,所有这些都将在单个1ml剂量中提供保护。这些产品含有独特的佐剂,由水中的水组成(免疫〜(TM))。本研究的目的是确定含有这种新辅助剂的菌株肺炎菌菌〜(TM)Myco和Panstar〜(TM),分别保护猪与My-Coplasma yercopneumoneae和Erysipelas Rhusiopathie的实验攻击。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号